ZIFF DAVIS, INC. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
ZIFF DAVIS, INC. (ZD) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $16.70 million for the 12-month period ending 2021-12-31, per its 10-K filed 2024-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2024-02-26
- ZIFF DAVIS, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2021-12-31 was $23.00K, a 360.00% increase year-over-year.
- ZIFF DAVIS, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2021-09-30 was $0.00.
- ZIFF DAVIS, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2021-06-30 was $16.70M.
- ZIFF DAVIS, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- ZIFF DAVIS, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2021 was $16.70M, a 14.82% decline from fiscal 2020.
- ZIFF DAVIS, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2020 was $19.61M, a 370.82% increase from fiscal 2019.
- ZIFF DAVIS, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2019 was $4.16M.
- ZIFF DAVIS, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2018 was $0.00.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $23.00K derived: sum of 2 quarters · filed 2024-02-26 | $16.72M derived: sum of 3 quarters · filed 2024-02-26 | $16.70M 10-K · filed 2024-02-26 | $16.68M 10-K · filed 2022-03-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $16.70M derived: sum of 2 quarters · filed 2022-11-09 | $16.68M 10-Q · filed 2021-11-09 | $16.70M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $16.70M 10-Q · filed 2022-11-09 | $16.68M 10-Q · filed 2021-08-09 | $16.70M derived: sum of 3 quarters · filed 2023-03-01 | $16.70M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | $5.00K derived: sum of 2 quarters · filed 2023-03-01 | $5.00K derived: sum of 3 quarters · filed 2023-03-01 | $5.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $5.00K derived: sum of 2 quarters · filed 2023-03-01 | $5.00K derived: sum of 3 quarters · filed 2023-03-01 | $19.61M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $19.60M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | $19.60M 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | $19.60M 10-Q · filed 2020-05-11 | ||||
| 2019-12-31 | $4.16M 10-K · filed 2021-03-01 | ||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-02 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TechTarget, Inc. (TTGT) | United States | $0.271B | -1.45 |
| Myseum.AI, Inc. (MYSE) | United States | $0.010B | -2.25 |